SCHEMBL20155980

SCHEMBL20155980

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4)ccc2n3-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c(C#N)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 2/20 0.37
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
PPARG P37231 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
CYP2C9 P11712 1/20 0.36
HTT P42858 1/20 0.36
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
CASP1 P29466 1/20 0.35
RECQL P46063 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150440 0.97 HPGD (0.40) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20155934 0.94 ALDH1A1 (0.43) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20150439 0.93 MAPK1 (0.41) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20114713 0.93 ALDH1A1 (0.41) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20115011 0.92 HPGD (0.44) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20156161 0.91 ALDH1A1 (0.41) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20156187 0.91 ALDH1A1 (0.44) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20114708 0.91 HPGD (0.40) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20156209 0.90 ALDH1A1 (0.40) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20114719 0.90 ALDH1A1 (0.39) HPGDALDH1A1LMNAMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 HPGD 2446/4885ALDH1A1 387/4885LMNA 3586/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 HPGD 2446/4885ALDH1A1 387/4885LMNA 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.